Business Description
Chongqing Lummy Pharmaceutical
NAICS : 325411
SIC : 2833
ISIN : CNE100000H10
Share Class Description:
SZSE:300006: Class ACompare
Compare
Traded in other countries / regions
300006.China IPO Date
2009-10-30Description
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.19 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | 14.09 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.54 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.1 | |||||
| 3-Year EPS without NRI Growth Rate | 50 | |||||
| 3-Year FCF Growth Rate | -54.5 | |||||
| 3-Year Book Growth Rate | 11 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.74 | |||||
| 9-Day RSI | 40.39 | |||||
| 14-Day RSI | 41.52 | |||||
| 6-1 Month Momentum % | -17.41 | |||||
| 12-1 Month Momentum % | -13.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.59 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.35 | |||||
| Days Inventory | 244.87 | |||||
| Days Sales Outstanding | 142.36 | |||||
| Days Payable | 61.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.1 | |||||
| Shareholder Yield % | 3.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.98 | |||||
| Operating Margin % | -4.3 | |||||
| Net Margin % | -1.16 | |||||
| FCF Margin % | 10.17 | |||||
| ROE % | -0.47 | |||||
| ROA % | -0.33 | |||||
| ROIC % | 0.61 | |||||
| ROC (Joel Greenblatt) % | 5.41 | |||||
| ROCE % | 0.9 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.36 | |||||
| PB Ratio | 1.38 | |||||
| Price-to-Tangible-Book | 1.57 | |||||
| Price-to-Free-Cash-Flow | 33.3 | |||||
| Price-to-Operating-Cash-Flow | 19.09 | |||||
| EV-to-EBIT | 106.46 | |||||
| EV-to-EBITDA | 106.46 | |||||
| EV-to-Revenue | 2.58 | |||||
| EV-to-FCF | 25.48 | |||||
| Price-to-Projected-FCF | 1.12 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 3.27 | |||||
| Price-to-Net-Cash | 90.33 | |||||
| Earnings Yield (Greenblatt) % | 0.94 | |||||
| FCF Yield % | 3.02 | |||||
| Forward Rate of Return (Yacktman) % | 15.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Lummy Pharmaceutical Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 850.058 | ||
| EPS (TTM) (Â¥) | -0.009 | ||
| Beta | 0.85 | ||
| Volatility % | 33.23 | ||
| 14-Day RSI | 41.52 | ||
| 14-Day ATR (Â¥) | 0.132013 | ||
| 20-Day SMA (Â¥) | 2.88 | ||
| 12-1 Month Momentum % | -13.77 | ||
| 52-Week Range (Â¥) | 2.03 - 4.75 | ||
| Shares Outstanding (Mil) | 1,055.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chongqing Lummy Pharmaceutical Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chongqing Lummy Pharmaceutical Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chongqing Lummy Pharmaceutical Frequently Asked Questions
What is Chongqing Lummy Pharmaceutical(SZSE:300006)'s stock price today?
The current price of SZSE:300006 is ¥2.71. The 52 week high of SZSE:300006 is ¥4.75 and 52 week low is ¥2.03.
When is next earnings date of Chongqing Lummy Pharmaceutical(SZSE:300006)?
The next earnings date of Chongqing Lummy Pharmaceutical(SZSE:300006) is .
Does Chongqing Lummy Pharmaceutical(SZSE:300006) pay dividends? If so, how much?
Chongqing Lummy Pharmaceutical(SZSE:300006) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers